ABSTRACT
Standard therapy for localized prostate cancer is radical prostatectomy. Experience since the mid-1990s has shown that radical surgery could not achieve local tumor control in patients with extracapsular extension of prostate cancer.1 Looking at long-term results of radical prostatectomy, clinicopathologic parameters influence cancer-specific and overall survival.2 Unfavorable risk factors like extraprostatic extension and seminal vesical involvement affect long-term biochemical recurrence-free survival.3
